Newsfile Corp
04 Jul 2026, 23:24 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
GeneDx cut its 2026 revenue guidance from a range of $540-$555 million down to $475-$490 million. — Significant downward revisions to annual revenue guidance typically lead to immediate and sharp valuation corrections.
-0.80GeneDx recorded a $31.3 million goodwill impairment charge on its Fabric Genomics acquisition, which was purchased for $36.5 million only one year prior. — A near-total write-down of an acquisition after one year indicates severe failure in strategic execution or overpayment, damaging management credibility.
-0.70The company's average reimbursement rate was $3,300, which was $200 below market expectations. — Lower-than-expected reimbursement rates directly squeeze gross margins and indicate pricing pressure in the core business.
-0.50Continue reading
6 related stories
Top 1 mover · tap to explore
A federal securities class action lawsuit has been filed against GeneDx alleging that executives made false or misleading statements regarding business prospects and margins. — Legal proceedings for securities fraud create long-term liability risks and can lead to significant settlements or regulatory scrutiny.
-0.40Which stocks this story touches
The company is facing a federal securities class action lawsuit following a 49% stock price drop, missed earnings, and cut revenue guidance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
4h ago
